A clinical study to see the effect of an Ayurvedic formulation in the treatment of Chronic Simple Rhinitis(common cold).

Phase 1/2

Completed

• Conditions: Chronic rhinitis,

• Registration Number: CTRI/2020/03/023837
• Lead Sponsor: Sane Guruji Arogya Kendra

Brief Summary

This study is open labelled randomized controlled clinical trial to evaluate the effect of Katphaladi Churna daily for 15 days in comparison with Tab Levocetrizine 5mg in combination with Montelukast 10mg of patients affected with Peenasa Vyadhi w.r.t Chronic Simple Rhinitis. The Primary outcome will be effect of Katphaladi Churna and the secondary outcome will be comparison between trial drug and control drug in management of Peenasa Vyadhi w.r.t Chronic Simple Rhinitis.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-04
• Last Update Posted: 2021-12-10

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

• 1. Patients from age group of 20 to 50 years.
• 2. Patients irrespective of gender and religion.
• 3. Patients having signs and signs and symptoms of Peenasaa Vyadhi(Chronic SimpleRhinitis) like Nasal Obstruction, Post-Nasal Drip, Partial loss of Smell(Anosmia).

Exclusion Criteria

• 1. Patients suffering from known case of chronic specific infective rhinitis like Syphilis, leprosy, T.B. lupus Vulgaris, Rhinosporidiosis, Rhinoscleroma, fungal Infections, leishmaniasis.
• 2. Patients with systemic diseases and known case of Hypertension, Respiratory disorder, Diabetes Mellitus, HBsAg, HIV.
• 3. Patients with DNS, Nasal polyp, Asthma, Tumors or any nasal pathology.
• 4. Patient not willing for treatment and irregular follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A clinical study to evaluate efficacy	The drug will be given 15 days. The patients will | be assessed before and after treatment. Total | duration of the study will 18 months.
of Katphaladi Churna in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis	The drug will be given 15 days. The patients will | be assessed before and after treatment. Total | duration of the study will 18 months.

Secondary Outcome Measures

Name	Time	Method
A comparison between efficacy	of Katphaladi Churna and Tab Levocetrizine 5mg in combination with Montelukast 10mg in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis

Trial Locations

Locations (1)

Sane Guruji Hospital,Hadapsar; 🇮🇳 Pune, MAHARASHTRA, India

Sane Guruji Hospital,Hadapsar

🇮🇳Pune, MAHARASHTRA, India

Vd Rochan Sharma

Principal investigator

8729009998

rochansrma@gmail.com